sk&f-38393 has been researched along with Breast Neoplasms in 2 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fazzari, J | 1 |
| Lin, H | 1 |
| Murphy, C | 1 |
| Ungard, R | 1 |
| Singh, G | 1 |
| Johnson, DE | 1 |
| Ochieng, J | 1 |
| Evans, SL | 1 |
2 other studies available for sk&f-38393 and Breast Neoplasms
| Article | Year |
|---|---|
Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Bone and Bones; Breast Neoplasms; Capsai | 2015 |
The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Breast Neoplasms; Cell Division; Dopamin | 1995 |